Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vita Coco Company's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vita Coco Company's regulatory disclosures and financial reporting.
The Vita Coco Company, Inc. completed the acquisition of Copra Inc., a producer of super-premium Thai Nam Hom coconut water, on July 22, 2026. Closing consideration totaled $175 million, composed of 467,071 Vita Coco shares and $140,000,210.59 in cash, with Copra shareholders also eligible for an additional earnout.
The aggregate earnout ranges from $45 million to $100 million based on Copra’s 2028 gross profit and will be paid in 2029 in cash, Vita Coco stock, or both, with at least 24% in cash. Copra expects full-year 2026 net sales above $100 million and has delivered a 48% net sales CAGR over the past three years.
Stock consideration was issued in a private placement, with Copra holders capped at 19.99% of Vita Coco’s pre-deal shares absent stockholder approval and granted registration rights for resale. Vita Coco expects the transaction to be accretive to its Adjusted EBITDA margins while maintaining mid-teens branded net sales growth and high-teens Adjusted EBITDA margin targets.
Wasatch Advisors filed an amended ownership report for Vita Coco Company, Inc., stating beneficial ownership of 2,255,360 shares of common stock, representing 3.9% of the class. Wasatch reports sole voting power over 1,542,909 shares and sole dispositive power over 2,255,360 shares, with no shared voting or dispositive power.
The filer indicates that it holds 5 percent or less of Vita Coco’s outstanding common stock. The report is signed by Mike Yeates, CEO of Wasatch Advisors.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $82.916 per share, executed under a pre-arranged Rule 10b5-1 trading plan. After this sale, he holds 580,296 common shares directly, plus a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
THE CHARLES SCHWAB CORPORATION reported proposed resale activity for Common Stock and discloses recent sales by an affiliate. The filing lists two past transactions by Kenneth Sadowsky: 3,900 shares sold on 04/15/2026 for $190,835 and 3,900 shares sold on 05/20/2026 for $302,150.
Vita Coco Company, Inc. director Ira Liran reported two open-market sales of common stock on June 12, 2026. One sale was 73,842 shares at a weighted average price of $80.322 per share, with trades ranging from $77.40 to $81.42. The other was 74,232 shares at a weighted average price of $80.292, within the same price range.
The filing notes these transactions were executed under a pre-arranged Rule 10b5-1 trading plan. After the sales, Liran’s reported holdings total 402,579 shares held indirectly through family trusts and 309,871 shares held directly, leaving him with about 712,450 shares overall.
Vita Coco Company, Inc. director Ira Liran reported selling 191,926 shares of Common Stock in open-market transactions. The shares were sold at a weighted average price of about $79.14 per share under a Rule 10b5-1 trading plan. After these trades, he holds 384,103 shares directly and 476,421 shares indirectly through the Ira Liran 2012 Family Trust and the Ira Liran Revocable Trust.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an option-related share sale. He exercised stock options to acquire a total of 30,000 shares of common stock at an exercise price of $10.178 per share, then sold 30,000 shares at $80.00 per share in an open-market transaction.
The filing states that the stock sales were made under a pre-arranged Rule 10b5-1 trading plan. After these transactions, Burth directly holds 57,910 shares of Vita Coco common stock and retains multiple non-qualified stock option awards with various exercise prices and expiration dates.
COCO reported a proposed sale of 30,000 shares of Common Stock via a stock option exercise. The filing lists the transaction date as 06/11/2026 and shows an aggregate dollar figure of $2,400,000.00 on the same line. The notice also lists multiple sales by Jonathan Burth totaling recent dispositions in March–May 2026.
Liran Ira reported acquisition or exercise transactions in this Form 4 filing.
Vita Coco Company, Inc. director Liran Ira reported a compensation-related stock grant rather than an open-market trade. He received 1,530 restricted stock units (RSUs) of common stock at a reference price of $75.18 per share under the company's 2021 Incentive Award Plan.
The RSUs vest in full on the earlier of the day immediately before the next annual stockholders meeting after the grant date or the first anniversary of the grant date, if he remains in continuous service. After this grant, Ira holds 479,871 shares directly and 572,579 shares indirectly through the Ira Liran 2012 Family Trust.